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Background: Pharmaceutical industry demands innovation for developing new molecules to improve
effectiveness and safety of therapeutic medicines. Preclinical assays are the first tests performed to evaluate
new therapeutic molecules using animal models. Currently, there are several models for evaluation of
treatments, for dermal oedema or infection. However, the most common or usual way is to induce the
inflammation with chemical substances instead of infectious agents. On the other hand, this kind of models
require the implementation of histological techniques and the interpretation of pathologies to verify the
effectiveness of the therapy under assessment.
This work was focused on developing a quantitative model of infection and oedema in mouse pinna. The
infection was achieved with a strain of Streptococcus pyogenes that was inoculated in an injury induced at
the auricle of BALB/c mice, the induced oedema was recorded by measuring the ear thickness with a digital
micrometer and histopathological analysis was performed to verify the damage. The presence of S. pyogenes
at the infection site was determined every day by culture.
Results: Our results showed that S. pyogenes can infect the mouse pinna and that it can be recovered at
least for up to 4 days from the infected site; we also found that S. pyogenes can induce a bigger oedema
than the PBS-treated control for at least 7 days; our results were validated with an antibacterial and anti-
inflammatory formulation made with ciprofloxacin and hydrocortisone.
Conclusions: The model we developed led us to emulate a dermal infection and allowed us to objectively
evaluate the increase or decrease of the oedema by measuring the thickness of the ear pinna, and to
determine the presence of the pathogen in the infection site. We consider that the model could be useful
for assessment of new anti-inflammatory or antibacterial therapies for dermal infections.
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The skin is our major barrier against biological
threats such as bacterial pathogens. An infection in
the skin usually begins with a damage or injury in
the epithelium. Pseudomonas aeruginosa and
Staphylococcus aureus are frequently involved in der-
mal infections, when the infection is localized n the
external auditory canal, it is commonly defined as ex-
ternal otitis [1, 2]. Streptoccocus pyogenes is a specific* Correspondence: jbravo@ciatej.mx
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after a previous dermal lesion [3].
There are several therapies for treating cutaneous
infections, some of them are delivered systemically or
applied locally; the last are topical substances which can
have anti-inflammatory and/or antibacterial effects [2].
Nowadays there are a plethora of new medical formula-
tions that have been analyzed to evaluate their thera-
peutic qualities against dermal diseases [4–6]. For the
assessment of those drugs is necessary to include evalua-
tions of both antibacterial and/or anti-inflammatory
effects, and these should be tested in a model that could
display most of the signals seen in dermal illness, such
as oedema, erythema, exudate and the etiological agentle is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
Marino-Marmolejo et al. BMC Microbiology  (2016) 16:290 Page 2 of 13in the site of infection. Several animal models, developed
to quantitatively evaluate the anti-inflammatory effect of
topical drugs, induce a dermal oedema usually localized
at the pinna or on external auditive canal through mech-
anical lesions [7]. These models require chemical sub-
stances such as 12-O-tetradecanoylphorbol-13-acetate
(TPA) [8–10], cantharidine [11], capsaicin [12, 13] or
Zymosan [14] to induce the oedema at the pinna.
Although there have been developed models of ear or
dermal infection with Pseudomonas, Candida [15],
Streptococcus pyogenes or Staphylococcus aureus [16]
and those models allow to analyze the infectious process,
it is not easy to quantitatively measure the induced
oedema. Because it is common that several treatments
or formulation could display both anti-inflammatory and
antibacterial effects [17] therefore, it would be useful to
analyze both effects in the same model.
The innovations in the development of new antibacter-
ial or anti-inflammatory drugs, or improving of the
current formulations or vehicles for their delivery,
require objective methods for their assessment. In fact, it
should be useful, that procedures not based in the
experience or human criteria exist. In this sense, it is
convenient to develop quantitative and robust methods,
that could be carried out in a blind way, and whose re-
sults would be reproducible. Likewise, the agent respon-
sible for inducing the inflammation or oedema, should
be a biological agent able to infect the host, because the
infection involves a more complex immunological
response than those induced by chemicals substances.
Methods
The aim of this work was to develop an animal model of
dermal infection in mouse pinna that emulate the signals
found in a typical cutaneous infection, that could be
reproducible and quantitative, for testing antibacterial
and/or anti-inflammatory therapies. Our results were
verified by using the standard histopathological tech-
niques for assessment of tissue damage. The model pre-
sented here involves the use of Streptococcus pyogenes as
inductor of skin infection and oedema on mouse auricle.
Although this bacteria is not a main skin pathogen,
some strains are able to cause secondary skin infections
such as impetigo [3]. On the other hand, it has been
already evaluated that S. pyogenes can infect skin in mice
[16, 18, 19].
Animals
Female BALB/c mice, 13- to 15-week-old (Harlan,
Mexico) were maintained in an environmental con-
trolled room (24 °C, artificial lightning with circadian
cycle of 12 h, ten air changes per h), and were allowed
free access (ad libitum) to standard food for mice
(Harlan, Mexico) and purified water; mice wereacclimated 3 weeks before any procedure. All experi-
ments were performed in aseptic areas, just before be-
ginning the experiments; each mouse was kept in
individual cages with sterilized wood shavings (Harlan,
Mexico). Ethylic ether vapors (Sigma Aldrich Co., St.
Louis, Mo) were used as anesthetic during procedures of
inoculation and measuring of ear thickness. We carried
out a strict surveillance to avoid animal suffering. In the
same way, all experiments were performed in accord-
ance with the government laws for Laboratory animal
care and use guidelines [20].
Strain
Streptococus pyogenes was the specie chosen for the
model; the strain was previously isolated from a 9 years
old child with impetigo. The strain was cultured in
Blood Agar (Becton and Dickinson, Mexico Ref 200150)
at 36.5 °C; after 18 h we inoculated three colonies in one
BALB/c mouse auricle, the pinna was pierced with three
23-gauge hypodermic sterile needles arranged in triangu-
lar shape. The mouse was maintained in a sanitized cage
during 3 days. After that, S. pyogenes was isolated in
blood agar from the infection site; the new strain was
labeled as R2. In order to induce adaptation to mice, the
strain R2 was inoculated again in another mouse, but
previously the strain was cultured 6 h at 37 °C in
Minimal Essential Medium (Sigma Aldrich Co., St.
Louis, Mo, Ref M0643) supplemented with 10% Fetal
Bovine Serum (ATCC, Manassas, VA, Ref 30–2020)
(MEM-FBS). The bacterial culture was centrifuged for
10 min at 3000 xg, the supernatant was discarded and
the bacterial pellet was resuspended and adjusted at 1 ×
1010 CFU/ml (previously, a nephelometric analysis and
viable count was carried out to quantify the CFU/ml
according to its absorbance at 600 nm). 10 μl of this
bacterial suspension was inoculated on the mouse pinna
following conditions previously described above. The
aim of this experiment was to recover the most adapt-
able S. pyogenes strain. A bacterial isolation was carried
out every day to recovery the most able strain to remain
in the infection site, and the strain recovered was labeled
as R3. We repeated this procedure 5 times more and we
obtained the R8 strain, which could remain 4 to 8 days
in the mouse pinna. This strain was sent to ARS Culture
and Patent Culture Collections in where is available, as
Streptococcus pyogenes B-50879.
Animal inoculation
B-50879 strain was cultured in (MEM-FBS) following
conditions previously described above, 3 h before inocu-
lation we recorded the weight of mice, and the auricles
of each mouse were sanitized with 0.1% benzalkonium
chloride. Mice were exposed to Ethylic ether vapor 15 to
20 min into a container which had a sterilized filter and
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tact of the solvent with the mouse. Just before inocula-
tion, the ear thickness was measured 5 times by using a
sanitized digital micrometer (Fowler, Newton, MA) that
has an accuracy of 0.01 mm, after that, the mouse pinna
was sanitized with 70% ethylic alcohol. The site of in-
oculation was injured with 3 punctures and immediately
was inoculated with 10 μl of 1 × 108 CFU of the B-50879
strain adjusted in phosphate buffer saline pH 7.2 (PBS)
(Gibco-Invitrogen, Grand Island, NY) as previously
described, after inoculation the mouse was returned to
its cage. Two areas in the mouse ear were tested for in-
oculation: The center of the pinna, that was pierced as
previously described, with a punch made with 3 nee-
dles arranged in a triangular shape and spaced 3 mm
and the edge of the pinna that was also pierced with
a 23-gauge hypodermic needle in three sites around
the auricle. After every measure or inoculation, all in-
strumental was sanitized with 70% ethanol, to avoid
cross-contamination.
Every day after inoculation, mice were weighted and a
swab (Becton Dickinson, Franklin Lakes, NJ, Ref
220131) from the inoculation site was cultured in blood
agar to verify if S. pyogenes were present, also the
induced oedema was recorded by measuring five times
the ear thickness with a digital micrometer as previously
described. Phenotypic test such as Pirrolidonyl arylami-
dase (PIR) test (Oxoid, Hampshire, United Kingdom)
and sensibility to Bacitracin (0.04 U. Oxoid, Hampshire,
United Kingdom) were performed to confirm the iden-
tity of S. pyogenes.
Morphological and histopathological analysis
Mice from each group at 2 to 6 days post-inoculation
were euthanized by cervical dislocation, and biopsies
from each auricle were collected, fixed in 10% Formalin-
PBS, and paraffin-embedded. The tissues were sliced at a
thickness of 10 μm by using a microtome (Leica,
Wetzlar, Germany), Gram and hematoxylin-eosin (HE)
stains were performed, and were observed in light
microscopy (Leica, Wetzlar, Germany). All microphoto-
graphs were captured by using a digital camera and ana-
lyzed with the software Infinity Analyze® (Lumenera
Corporation, Ottawa, Canada). Leucocyte infiltration in
infected pinna and PBS-treated pinna were semi quanti-
fied in the HE preparations, total inflammatory cells
were counted from 8 fields at 50x.
Hematological assays
Blood samples from mice in each group were collected
in the presence of EDTA, before and 24 h post-
inoculation. 10 μl of blood were diluted 1:40 in Turk
reagent (Merck, Darmstadt, Germany) and total leuko-
cytes were counted by light microscopy by using thehemocytometer (Hausser Scientific, Horsham, PA).
Differential count of leukocytes was performed by stain-
ing blood slides with Wright’s reagent (Sigma Aldrich
Co., St. Louis, Mo, Ref WS32) according to manufac-
turer’s instructions, and 200 cells were counted under
light microscopy so as to quantify the number of
neutrophils.
Protocol of validation
A commercial treatment made with Ciprofloxacin
2 mg/ml, Hydrocortisone 10 mg/ml and Benzocaine
20 mg/ml (Sodrimax®, PiSA Farmaceutica, Mexico)
was used as antimicrobial and anti-inflammatory
standard, for comparison we used a sterilized glycerol
50% in PBS as placebo. All treatments were main-
tained and delivered in a double-blind way. Twelve
mice were inoculated with S. pyogenes B-50879 in
both pinna as previously mentioned. Treatments were
evaluated in two ways: as curative, in where both for-
mulations were applied 24 after the inoculation; and
as preventive way, in where the treatments were
administered 1 h after inoculation. 10 ul from each
solution was delivered on the pinna surface every 8 h
during 8 days, every day in the morning before the
treatment, was taken a swab from the pinna and was
measured the ear thickness. When the protocol fin-
ished, animals were euthanized, following the govern-
ment laws for Laboratory animal care and use
guidelines [20]. Bacterial presence and absence was
compared in the infected pinna treated with antibac-
terial o placebo treatments, furthermore the oedema
inhibition was evaluated with data collected from the
ear thickness measurements during the protocol and
compared with the placebo.
Statistical analysis
Results are expressed as mean of the group ± standard
error of the media (SEM), paired t student test was used
for intragroup comparison (dependent variable influ-
enced by the individual, for example left vs right pinna
or placebo vs treatment). Non-paired t student test was
applied when two independent groups were compared
(Group treated with S. pyogenes vs group control-PBS-
treated). Statistical analysis was performed every day
between two groups considering p <0.05 as significant.
Using a variant of the surviving test, in which the time
of permanence of S. pyogenes at the infection site was
analyzed, compared the permanence of S. pyogenes,
Wilcoxon test was used to infer statistical difference
considering p <0.05 as significant. x2 test was used to
evaluate differences between placebo and antibacterial
treatment with a 2 × 2 contingency table according to
the Mantel Haenszel procedure, considering p <0.05
as significant. All statistical tests were carried out in
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Technologies, Warrenton, VA).
Results
Animal models are useful for research in medical
sciences. They aim to emulate the classical signs of the
illness; for models of dermic infection the evidence of
inflammation and infection should be demonstrated. S.
pyogenes B-50879 was used in our method as an infec-
tious agent able to cause a quantifiable oedema. We
performed morphologic and histopathological analysis as
well as microbiologic assays to ensure the signals of der-
mic infection. On the other hand, quantitative analysis
of eodema was performed, to assess its reproducibility
and utility, to differentiate inflammation caused by the
procedure, from the inflammation caused by the dermic
infection.
Histopathological and morphological findings
S. pyogenes B-50879 could induce an inflammatory re-
sponse, when it was inoculated on an injured mouse
pinna. Polymorphonuclear cells were abundant in tissues
infected, we also observed hyperplasia in the spinosum
stratum and important oedema into the dermis.
Although the process needed for the infection involve
inducing damage on the pinna, we found that PBS-Fig. 1 Dermal oedema induced by S. pyogenes. Microphotographs of B
The pictures were captured with an objective of 10x and the squares s
4 and 6 days post inoculation with S. pyogenes respectively, the arrow
and f) PBS-treated control at 2, 4 and 6 days after inoculation respectitreated controls did not show the same number of
inflammatory cells or the same magnitude of oedema
induced by the bacterium (Fig. 1). Total Inflammatory
cells from tissues at 48 h were semi quantified in order
to determine the leukocyte infiltration on histological
preparations, we found 4 times more inflammatory cells
(an average of 78 vs. 18 cell/40X field) into the tissues
infected with S. pyogenes in comparison with PBS-
treated control, the difference was statistically significant
(Non-paired t student, P = 0.0026).
When we inoculated S.pyogenes without previously-
induced damage, we found neither inflammatory cells
nor oedema into the tissue, showing similar results as
the control non-inoculated; (Fig. 2). All histopathological
findings agreed with signals observed in dermal
infections.
Mice pinna infected with S. pyogenes showed an in-
crease in its thickness, erythema, yellow-colored crusts
and delivery of purulent liquid. Most of the lesions
healed during the first 6 days; however, a 5th part de-
layed its healing until 8 to 10 days, (Fig. 3). PBS-treated
control showed lower erythema, although we found
crusts in the site of inoculation, it was smaller and they
healed in an average of 5 days, also we did not observe
purulent liquid in any of these animals. Some infection
can affect the weight of the host; however, we did notALB/c mouse pinna after inoculation in a previous injured area.
how the 500× magnification. a, c and e) Mouse pinna after 2,
shows white areas that might be oedema into the tissue. b, d
vely
Fig. 2 Effect of the physical injury on the mouse pinna in the development of oedema caused by the inoculation of S. pyogenes. The
photographs were captured with an objective of 10x and the squares show the 500x magnification. a, c and e) Histological changes
observed in the pinna at 2, 4 and 6 days post inoculation respectively, the infection was carried out on a previous injured mouse auricle.
b, d and f) No changes were observed in the pinna at 2, 4 and 6 days post inoculation when the bacterium was delivered in the skin
of the auricle without any injury
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(data not shown).
We found that 2 of 54 mice (in a total of five experi-
ments: n = 10, n = 14, n = 16, n = 7, n = 7) developed a
heightened inflammatory response with the presence of
a crust that prevented proper measurement of the ear
thickness (Fig. 3, 144 h). To avoid affecting the accuracy
of the method we decided to disregard the data from
these animals.
Infectious diseases often induce an increase in leuko-
cytes from the peripheral blood; the infection conducted
in mouse pinna showed that there was only a significant
increase of neutrophils 24 h after inoculation (P =
0.0016), but the total counts of leukocytes were not
significantly different when we compared results be-
fore and after inoculation. PBS-treated control group
did not show difference in neutrophils or in total
leukocytes. (P = 0.33) (Fig. 4).Bacterial clearance at the site of infection
We observed that S. pyogenes could survive near to the
infection site. Sections of infected tissue stained by
Gram showed bacterial cocci that resemble streptococ-
cus, the bacteria were visible into the tissue until 6 dayspost-inoculation, PBS-treated controls did not show any
bacteria into the tissue (Fig. 5).
Swabs obtained from the site of inoculation were cul-
tured; S. pyogenes was isolated from infected auricles but
not from controls. Mice could clear the bacteria, but we
found that a little damage induced by the inoculation,
caused that S. pyogenes remained an average of 107 h in-
stead of 56 h recorded in non-injured pinna. We found
that 100% of mice inoculated by S. pyogenes without
damage could clear the bacterium in 96 h, while
100% of mice inoculated in lesions delayed until
192 h to eliminate it, the difference was statistically
significant (p <0.00001, Wilcoxon test) (Fig. 6).
These results show that S. pyogenes can remain in the
model of infection, and could be easily detected by a
standard culture from the infection site.Best conditions for the model of dermal infection
One of the main aims of this study was to develop a
quantitative model of dermal infection, the aim was to
discriminate among different levels of severity in the in-
fection and inflammation; we tested 2 areas of inocula-
tion to find the best one for developing the model. Both
selected areas were localized on the auricle, because of
Fig. 3 Macroscopic effect observed in auricle infected with the S. pyogenes strain B-50879. Auricles from mice inoculated over a small damage,
the squares show a 30x magnification of the indicated area. S. pyogenes could cause exudate, erythema, eschars and delivery of purulent liquid.
The PBS-treated control only showed a small erythema all-around the injury previously induced; finally, the damage could heal faster than ones
inoculated with the bacterium
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precise measures.
When the infection was performed at the marginal edge
of the auricle, the increase of the ear thickness induced
was statistically different to the PBS-treated control, butFig. 4 Hematological effect of inoculation of S. pyogenes on mouse pinna.
inoculation of S. pyogenes on damaged mouse pinna (n = 24, p = 0.0011; pa
after the inoculation, (n = 14, p = 0.33; paired t student test)only the first 2 days post-inoculation (p <0.047, Fig. 7a).
On the other hand, when the center of the auricle was in-
fected, the oedema induced was bigger and there was a
statistic difference versus PBS-treated control during the
first 6 days post-inoculation (p <0.048, Fig. 7b). All thoseA significate increase of neutrophils was recorded 1 day after the
ired t student test). The PBS-Treated control did not show differences
Fig. 5 Gram stain that shows cocci into the mouse pinna previously infected with S. pyogenes strain B-50879. The images are representative fields
at 40x of the tissue from pinna of mice infected or PBS-treated after previous damage and stained with GRAM. The squares were amplified with
the immersion oil objective to show a 1000x magnification. a, c and e are tissue infected with S. pyogenes at 48 h, 96 h and 144 h post inoculation.
b, d and f are tissue treated with PBS at 48 h, 96 h and 144 h respectively
Fig. 6 Permanence of S. pyogenes in the pinna. The image represents the likely of recovery S. pyogenes from a mouse pinna after the process
of inoculation, a previous damage on the mouse pinna (n = 50), let us to recover bacteria after longer time than pinna without injury (n = 12).
Wilcoxon test P <0.00001
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Fig. 7 Best area for inoculation. We used two ways to inoculate S. pyogenes on the mouse pinna, in both methods the pinna was pierced with
23-gauge hypodermic needles over three points; the graphs show the average between the increases of the ear thickness caused by the damage
on the pinna and recorded every day. S. pyogenes was inoculated in one pinna while the contralateral was inoculated with PBS as control, the
deviation bars show SEM. a Inoculation near to the edge of the auricle: we found statistical difference in ear thickness during the first 2 days after
the inoculation (n = 8, p <0.047 paired t student test). b Inoculation at the center of the auricle with a punch made with 3 needles arranged in a
triangular shape: we found a statistical difference in ear thickness during 6 days post-inoculation, (n = 8, p <0.048 paired t student test)
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oping the model.
The increase of the ear thickness induced by the S.
pyogenes, was tested in mice without any damage, the in-
oculation on the auricle did not cause any change in the
ear thickness, only when the bacterium was inoculated
on a previous lesion, we observed a statistically signifi-
cant increase of the ear thickness, (p <0.0002, Fig. 8a).
S. pyogenes apparently can induce an increase of the
ear thickness, however that increase could be caused by
the antigenic proprieties of the bacterium instead of the
infection process. We carried out inactivation of S. pyo-
genes by 3 cycles of freezing and thawing of a suspension
with 1 × 1010 CFU/ml in PBS, four mice with damaged
auricles as previously described above, were treated by
using this inoculum, we confirmed the inactivation
process by culturing 10 μl of the suspension. During the
next 5 days after inoculation, we measured the earthickness; there was no difference with the PBS-treated
control group (p > 0.15, Fig. 8b). These results confirm
that S. pyogenes can induce a dermal infection and is the
cause of the oedema on the inoculation site.
Strength and precision
Both auricles from the same animal were inoculated
with S. pyogenes at 1 × 108 CFU or PBS (n = 14); the
process was carried out in a blind way. Every day during
10 days the increase of the ear thickness was measured,
and we found statistic difference during the first 7 days
post-infection between the infected pinna and the con-
trol pinna (p <0.0046, Fig. 8c). On the other hand, the
magnitude of the oedema caused by S. pyogenes was
compared; when the bacterium was inoculated into the
left or right pinna from eight mice, there was no differ-
ence between the left or right pinna during all experi-
ments (p > 0.12, Fig. 8d). We assessed the precision of
Fig. 8 Experimental conditions for the model. The increase of the ear thickness (oedema) after inoculation was evaluated considering some
experimental conditions. The statistical analysis was performed comparing daily the increase of the ear thickness, induced by S. pyogenes in
contrast with the PBS control, the deviation bar shows the SEM. a Two independent groups were tested, in both, a little damage was performed
at the mouse pinna, we found statistical difference (*) during 8 days post inoculation (n = 8, p <0.0002, non-paired t student test) between S.
pyogenes and PBS-control. We evaluated 2 independent groups but without injury, and we did not find difference in the ear thickness between
mice inoculated with S. pyogenes or PBS (n = 5). b Two independent groups were compared: mice inoculated with S. pyogenes viable and mice
inoculated with S. pyogenes inactivated, both in injured pinna. The inactivated bacteria failed to induce the oedema, and when it was compared
with PBS-treated control there was not difference (n = 4 p > 0.15, non-paired t student test). c One group was inoculated in both damaged pinna,
one of them were infected with S. pyogenes and the contralateral was de control, treated with PBS, we found statistical difference during 7 days
post-inoculation (n = 14, p < 0.0046 paired t student test). d There was no difference between the oedema caused by S. pyogenes in the right or
left pinna (n = 8, p > 0.12, paired t student test)
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variation coefficient of the increase of ear thickness;
results are shown in Table 1.
Validation of model of dermal infection
A robust model of dermal infection should present not
only accuracy and reproducibility, but also it should dis-
play expected results with standard anti-inflammatory or
anti-microbial drugs. We carried out a protocol where
we infected 12 mice following the consideration aboveTable 1 Precision in the measure of the increase of the ear thicknes
Days after inoculation
1 2 3 4 5
Mean (mm) 0.547 0.586 0.524 0.402 0
Median (mm) 0.553 0.666 0.529 0.357 0
SD 0.128 0.140 0.134 0.180 0
Va 23.424 23.935 25.530 44.916 26
a V = Coefficient of variation, expressed as percentagementioned, when we applied the antibacterial formula-
tion that contain ciprofloxacin. In a curative way we can
observe that S. pyogenes is able to remain into the in-
fected pinna during 5 days, only 2 days less than placebo
(Fig. 9a) in contrast when the treatment was adminis-
tered as a preventive way, just 1 h post-inoculation, the
bacterium was only able to resist 2 day the antibacterial
effect (Fig. 9b) In both administration ways S. pyogenes
were eliminated from the infection site before the in-
fected pinna treated with placebo. We found that otics
6 7 8 9 10
.336 0.393 0.281 0.149 0.063 0.036
.315 0.389 0.252 0.116 0.062 0.022
.089 0.065 0.095 0.081 0.043 0.062
.488 16.534 33.630 54.383 79.277 170.659
Fig. 9 Effect of a standard treatment on the model of dermal infection and oedema. We analyze the effect of an otic formulation made with
Ciprofloxacin as antibacterial and Hydrocortisone, Benzocaine as anti-inflammatory treatment on a dermal infection induced by S. pyogenes, The
bacterium was inoculated in both pinna of 12 mice as previously mentioned, and the treatment was assessment in comparison with a placebo.
Two kind of application were evaluated: as a curative (24 h post inoculation) or preventive (1 h post-inoculation). Treatments were applied in a
blind way but considering that one infected pinna was exposed to the standard treatment and the contralateral was treated with a placebo
(glycerol 50%). a Antibacterial effect of curative treatment applied 24 h post inoculation, S. pyogenes could resist the first 5 days of the treatment
with the ciprofloxacin in the standard formulation, we found statistical difference only from the 5 to 6 day of treatment in comparison with
placebo (p <0.034, x2 test). b Antibacterial effect of preventive treatment, when the standard formulation was applied 1 h post inoculation, we
could observe that S. pyogenes was not able to survive more than 2 days in presence of the antibiotic, we found statistical significant difference
during the first 5 days (p <0.0285, x2 test). c Anti-inflammatory effect of the curative treatment. 24 h after inoculation, S. pyogenes caused an
increase of the ear thickness that represent 100%, when applied the formulation with hydrocortisone as standard anti-inflammatory drug, we
found a decrease in the ear thickness that was statistically significant with the placebo during the first 3 days (p <0.026, paired t student test).
d Anti-inflammatory effect of the preventive treatment. 1 h after inoculation of S. pyogenes, the pinna were treated with the formulation, we
found that standard anti-inflammatory drugs was able to prevent the increase in thickness observed in placebo-treated pinna, the difference
was significant during the first 3 days (p <0.0032, paired t student test)
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important anti-inflammatory effect when it was adminis-
tered in both ways tested here: curative (Fig. 9c) and
preventive (Fig. 9d) the differences when are compared
with the placebo are notorious during the first 3 days
post-inoculation, however when the treatment was ap-
plied in a preventive way, we noticed that practically
prevented the increase in the ear thickness, as compared
to that observed with the placebo-treated pinna.
Discussion
Preclinical assays should be tested in models that emu-
late the common signs found in the disease. In the caseof dermal infections, a useful model should show the in-
flammatory process and also the presence of infectious
agent. Most animal models also display differences in
their susceptibility to several microorganisms. S. pyo-
genes, a recognized human pathogen [21] was selected
as infectious agent, as some strains are able to infect
skin [22, 23] and are responsible for cases of erysipelas
or impetigo [24, 25]. On the other hand, there are evi-
dence that S. pyogenes can also infect BALB/c mice in a
previous injury on the dermis [16]. Our strain was previ-
ously isolated from a patient with impetigo, where we
isolated a strain that can infect mice skin, based on im-
proved fitness for in vivo growth. Even though we are
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prove such phenotype at a population level, or how
stable over serial subcultures this phenotype is, we
achieved an increase of the ear thickness at least 2 times
bigger than non-inoculated control, (52 of 54 test in a
total of 5 independent experiments), in more than 95%
of the mice infected with S. pyogenes B-50879. Taking
into account the above, we consider that our strain is
stable and therefore is available in ARS Culture and
Patent Culture Collections. Therefore, we consider that
our strain has the requirements for using it as infectious
agent in the present model.
The adaptation to different mice breed would be worth
assessing, although for this particular study it was out of
our scope. As it is known that the skin harbors many
immune cells (Langerhans cells; keratinocytes; dendritic
epidermal T lymphocytes; epidermotropic lymphocytes;
and melanocytes, epidermal pigment cells with immune
properties) [26] as well as B cells [27], some heterogeni-
city in host response might exist.
Although some strains of S. pyogenes can infect skin, it
is necessary that a previous lesion or damage in the epi-
thelium exists, so once the bacterium has infected it,
these can spread to other areas [2, 3, 24, 28]. When S.
pyogenes was inoculated in mouse pinna without a previ-
ous lesion, the bacterium did not infect the auricle, and
there was not an evident change in the mouse pinna.
Those results show the importance of the previous
lesion to achieve the infection, and agree with previous
works where is also necessary to induce a lesion before
inoculation [19, 29, 30].
Human cutaneous infections induced by S. pyogenes
frequently develop abscess, erythema and crusts, also
there are leukocytes released in the exudate from those
lesions [2, 3, 24]. In BALB/c mice infected by the strain
S. pyogenes B-50879, we observed similar signs and coc-
cid bacteria into the infected tissue. In a mice model of
infection in the dorsal area, it has been recorded that S.
pyogenes can be maintained in the animal 3 to 5 days
post-inoculation [16, 18]. Our model showed similar
results, where 108 h was the average time in where we
could recover the bacterium from the infection site,
although in some cases the bacterium was recovered up
to 8 days post-inoculation. We consider that this time is
enough for assessing the antibacterial effect of any
treatment.
Tissues infected by the strain S. pyogenes B-50879
showed an increase of the keratinized squamous epithe-
lium stratum, oedema and infiltration of polymorpho-
nuclear leukocytes into the connective tissue. These data
agree with an infection model of external otitis, devel-
oped in rats infected with Pseudomonas aeruginosa or
Candida albicans [15]. In order to verify that an infec-
tion process instead of an inflammatory responsestimulated by bacterial antigens caused our results, we
inoculated the same bacterial load but as non-viable
microorganisms, the results showed similar findings as
the PBS-treated control. Those results led us to consider
that an infection process produced by S. pyogenes in fact
induced the inflammatory response we observed.
All injury into the skin involves tissue damage that
might induce an inflammatory response. A previous
model was developed by a mechanical lesion into the
external ear canal [31]. Our model requires a previous
injury at the pinna, which in fact induces an increase of
the ear thickness, however it is statistically lower than
the oedema induced by the S. pyogenes inoculation. That
difference is observed at least 7-days post-inoculation, a
period of time that might be useful for testing the anti-
inflammatory efficacy of treatments.
Infectious diseases can induce a release of poly-
morphonuclear leukocytes into the infected tissues; we
observed an increase of these cells in peripheral blood as
well as tissues inoculated with the bacterium. Consider-
ing all results presented here we conclude that S. pyo-
genes B-50879 is able to cause a localized infection in a
mice pinna, that induce an oedema similar to other
models, and that furthermore can emulate the typical
signs found in human dermal infections.
Although there are previous models of dermal infec-
tion in mice by using S. pyogenes [16, 18, 19], those are
not quantitative models, because the infection is induced
in anatomical areas that are not easily accessible to
obtain measures of eodema, and the inflammatory diag-
nosis is based in histopathological resources, that might
be susceptible to ambiguous results in mice with differ-
ent severity of disease.
Analytical methods require objective measures; this is
not an exception from animal models developed to as-
sess the anti-inflammatory effect of molecules. However,
many of them require histopathological methods [15],
which could increase the cost and time of process
because it would be indispensable that interpretation is
carried out by a pathologist. However, it is likely that
two results from the same sample do not display similar
results, because the interpretation is based in personal
criteria. Previously, there have been developed several
quantitative models of inflammation considering: the
measure of the ear thickness by using a micrometer
[4, 32, 33]; the weight of biopsies from mice’s auricle,
previously stimulated by chemicals [11, 34, 35]; or
even through the microscopic measure of the tissue
thickness from histopathological slides [8]. The model
of dermal infection described in this work considered
the anatomical advantage of mouse pinna because it
has a flat shape, that let us to obtain precise mea-
sures of the ear thickness, directly related with the
oedema. The main difference with previous models is
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and inflammation instead of chemicals that can in-
duce oedema but not infection, limiting its use for
assessing anti-inflammatories proprieties [4, 9, 11].
Our model emulates a dermal infection, which is
characterized by a localized lesion, erythema, exudate
and oedema, we confirmed that results with conven-
tional histopathological methods, in where we ob-
served inflammatory cells, also there was an increase
in the number of peripheral blood neutrophils, spe-
cific leukocytes specialized to clear bacterial infec-
tions. In order to determine if the model developed is
useful for testing anti-inflammatory and antibacterial
formulations, we carried out a protocol where we
tested the antibacterial effect of ciprofloxacin, anti-
biotic that has been previously tested as otic formula-
tions [36, 37], and anti-inflammatory effect of
hydrocortisone, which has been used as standard of
anti-inflammatory effect in skin [4]. Our results
showed that the model is useful when the drugs are
tested in a curative way as well as preventive way.
We consider that the method also can be useful for
testing anti-inflammatory treatments, because our
results showed the expected anti-inflammatory re-
sponse in the pinna treated with the hydrocortisone
contained in the formulation, the results presented
here, were similar to the oedema inhibition after the
treatment with the anti-inflammatory treatment, in a
model of oedema stimulated by TPA [4, 9]. However,
we consider that our model has an advantage,
because in fact it is emulating the dermic inflamma-
tion caused by the infection.
All findings agree with the hypothesis that S. pyogenes
B-50879 is able to cause an infection in the mouse pinna
in where it is possible to track the presence of the patho-
gen, evaluate consequences of infection such as oedema
through the measure of the ear thickness, as well as to
test new potential treatments with antibacterial or anti-
inflammatory effect.
Conclusions
The best method tested for developing a precise oedema
was to inoculate S. pyogenes in a previous lesion in the
center of auricle. The increase of the ear thickness was
consistent and in all experiments, we could observe an
increase close to 3 times the original size of the auricle,
instead of 1.5 observed for the PBS-treated control; this
difference was statistically significant. The magnitude of
the oedema induced by our method was similar to those
induced by TPA [4, 9], croton oil [38] and was bigger to
the one induced by mustard oil [33, 39] or capsaicin
[13]. The difference was statistically significant during 7-
days post-inoculation and the precision observed was
adequate to differentiate auricles inoculated withcontrols from those infected by S. pyogenes. Similar re-
sults were found when the experiment was conducted in
paired design (comparing left and right auricles from the
same animal) or non-paired design (when were com-
pared different groups of animal such as control group
or infected group), even when the experiment was per-
formed in a blind way. These results support the conclu-
sion that our model is strong and robust, and we
recommend to use this animal model in randomized
designs performed in a blind way. The method is also
useful for testing molecules or treatments with anti-
inflammatory or antibacterial proprieties.
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